Litcius/Paper detail

Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors

Hirono Tsutsumi, Hiroyuki Inoue, Yoshimasa Shiraishi, Aiko Hirayama, Takayuki Nakanishi, Hiroyuki Ando, Maako Nakajima, Seiji Shinozaki, Hiroaki Ogata, Koji Okamura, Shinichi Kimura, Tomohiro Ogawa, Keiichi Ota, Yasuto Yoneshima, Kentaro Tanaka, Naoki Hamada, Isamu Okamoto, Eiji Iwama

2023Lung Cancer10 citationsDOI

Topics & Concepts

MedicineCalreticulinInternal medicineOncologyLung cancerDampChemotherapyImmune systemNivolumabHazard ratioCancerImmunotherapyGastroenterologyImmunologyEndoplasmic reticulumPhysicsMeteorologyConfidence intervalChemistryBiochemistryCancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease PrognosisInflammasome and immune disorders
Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors | Litcius